Current understanding of prostate cancer biomarkers

被引:0
|
作者
Popov, S. V. [1 ,2 ]
Guseynov, R. G. [1 ,2 ,3 ]
Vasin, A. V. [4 ]
Sivak, K. V. [1 ,5 ]
Pomeshkin, E. V. [1 ]
Perepelitsa, V. V. [1 ,2 ]
Bunenkov, N. S. [1 ,6 ,7 ]
Lelyavina, T. A. [7 ]
机构
[1] St Lukas Clin Hosp, 46 Chugunnaya St, St Petersburg 194044, Russia
[2] St Petersburg Med & Social Inst Let, 72 Kondratievskiy Prospekt, St Petersburg 195271, Russia
[3] St Petersburg State Univ, 7-9 Univ Skaya Naerezhnaya, St Petersburg 199034, Russia
[4] Peter Great St Petersburg Polytechn Univ, Inst Biomed Syst & Biotechnol, 29 Polytech Skaya, St Petersburg 195251, Russia
[5] AA Smorodintsev Res Inst Influenza, 15-17 Prof Popova St, St Petersburg 197022, Russia
[6] IP Pavlov First St Petersburg State Med Univ, 6-8 Lva Tolstogo St, St Petersburg 197022, Russia
[7] VA Almazov Natl Med Res Ctr, 2 Akkuratova St, St Petersburg 197341, Russia
来源
ONKOUROLOGIYA | 2023年 / 19卷 / 04期
关键词
prostate cancer; biomarker; prostate biopsy; diagnostics; prognosis; HEALTH INDEX PHI; DIAGNOSTIC PERFORMANCE; GENOMIC CLASSIFIER; BIOPSY; VALIDATION; PREDICTOR; 4KSCORE; MEN;
D O I
10.17650/1726-9776-2023-19-4-148-157
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Worldwide, prostate cancer has remained one of the most common malignant neoplasms among men and it is accompanied by high mortality rates. Standard methods for diagnosing prostate cancer have limited sensitivity and specificity, unnecessary biopsies are often performed, and the risk of overdiagnosis of the disease and overtreatment of patients is high. The review considers diagnostic and prognostic biological markers of prostate cancer proposed in recent years. Theoretical foundations for the use of new biomarkers are analyzed. The characteristics and practical significance of biomarkers of various groups (immunohistochemical, molecular and genetic, prostate specific antigen-associated, volatile organic metabolites) are presented. The need for further large-scale scientific research in the field of biomarker application in prostate cancer, criteria for their selection and evaluation are described. The introduction of modern diagnostic and prognostic markers into real clinical practice opens up new opportunities for improvement of prostate cancer diagnosis, individual prognosis, and rationalization of treatment strategy.
引用
收藏
页码:148 / 157
页数:10
相关论文
共 50 条
  • [31] A Personalized Approach for Oligometastatic Prostate Cancer: Current Understanding and Future Directions
    Alerasool, Parissa
    Zhou, Susu
    Miller, Eric
    Anker, Jonathan
    Tsao, Brandon
    Kyprianou, Natasha
    Tsao, Che-Kai
    CANCERS, 2025, 17 (01)
  • [32] Current Understanding of Asthma Pathogenesis and Biomarkers
    Habib, Nazia
    Pasha, Muhammad Asghar
    Tang, Dale D.
    CELLS, 2022, 11 (17)
  • [33] Understanding how prostate cancer patients value the current treatment options for metastatic castration resistant prostate cancer
    Benidir, Tarik
    Hersey, Karen
    Finelli, Antonio
    Hamilton, Rob
    Joshua, Anthony M.
    Kulkarni, Girish
    Zlotta, Alexandre
    Fleshner, Neil
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2018, 36 (05) : 240.e13 - 240.e20
  • [34] Understanding prostate cancer
    Siddiqui, E
    Mumtaz, FH
    Gelister, J
    JOURNAL OF THE ROYAL SOCIETY FOR THE PROMOTION OF HEALTH, 2004, 124 (05): : 219 - 221
  • [35] A review of current clinical biomarkers for prostate cancer: towards personalised and targeted therapy
    Osei, Ernest
    Swanson, Steph
    JOURNAL OF RADIOTHERAPY IN PRACTICE, 2022, 21 (02) : 277 - 286
  • [36] Biomarkers in Prostate Cancer Diagnosis: From Current Knowledge to the Role of Metabolomics and Exosomes
    Salciccia, Stefano
    Capriotti, Anna Laura
    Lagana, Aldo
    Fais, Stefano
    Logozzi, Mariantonia
    De Berardinis, Ettore
    Busetto, Gian Maria
    Di Pierro, Giovanni Battista
    Ricciuti, Gian Piero
    Del Giudice, Francesco
    Sciarra, Alessandro
    Carroll, Peter R.
    Cooperberg, Matthew R.
    Sciarra, Beatrice
    Maggi, Martina
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (09)
  • [37] The Current Landscape of Prostate-Specific Membrane Antigen (PSMA) Imaging Biomarkers for Aggressive Prostate Cancer
    Al Saffar, Haidar
    Chen, David C.
    Delgado, Carlos
    Ingvar, Jacob
    Hofman, Michael S.
    Lawrentschuk, Nathan
    Perera, Marlon
    Murphy, Declan G.
    Eapen, Renu
    CANCERS, 2024, 16 (05)
  • [38] Understanding mixed messages about prostate specific antigen: Biases in the evaluation of cancer biomarkers
    Ankerst, Donna Pauler
    Thompson, Ian M.
    JOURNAL OF UROLOGY, 2007, 177 (02): : 426 - 427
  • [39] New biomarkers of prostate cancer
    Hanouskova, L.
    Kotaska, K.
    Prusa, R.
    Rezac, J.
    Vesely, S.
    CLINICA CHIMICA ACTA, 2019, 493 : S119 - S119
  • [40] Biomarkers for prostate cancer detection
    Parekh, Dipen J.
    Ankerst, Donna Pauler
    Troyer, Dean
    Srivastava, Sudhir
    Thompson, Ian M.
    JOURNAL OF UROLOGY, 2007, 178 (06): : 2252 - 2259